RSS

Epilim (sodium valproate)

The Medicines and Healthcare products Regulatory Agency (MHRA) has implemented changes to the licence for valproate medicines — Epilim, Depakote and generics used to treat epilepsy and bipolar disorder — in the interest of public safety. Read more

News

This episode sees the editors (as well as their not-so-invisible fact checker!) come together to chat about the latest developments in the worlds of medtech, digital health, medical plastics and pharma. Read more

Opinion

Episode three of the MedTalk Podcast features the regulation of contraceptive apps, how sensors can be used to help detect and monitor bone frailty and the public hearing on sodium valproate. Read more

News

Antiepileptic drugs and the potentially harmful effects on unborn children has hit the headlines as a survey reveals many women have not received the new safety warnings about the dangers of taking it during pregnancy. Read more

News